Correlation Between Biodexa Pharmaceticals and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Biodexa Pharmaceticals and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biodexa Pharmaceticals and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biodexa Pharmaceticals and Entero Therapeutics,, you can compare the effects of market volatilities on Biodexa Pharmaceticals and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biodexa Pharmaceticals with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biodexa Pharmaceticals and Entero Therapeutics,.
Diversification Opportunities for Biodexa Pharmaceticals and Entero Therapeutics,
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Biodexa and Entero is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Biodexa Pharmaceticals and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Biodexa Pharmaceticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biodexa Pharmaceticals are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Biodexa Pharmaceticals i.e., Biodexa Pharmaceticals and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Biodexa Pharmaceticals and Entero Therapeutics,
Given the investment horizon of 90 days Biodexa Pharmaceticals is expected to generate 1.27 times more return on investment than Entero Therapeutics,. However, Biodexa Pharmaceticals is 1.27 times more volatile than Entero Therapeutics,. It trades about -0.1 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.22 per unit of risk. If you would invest 624.00 in Biodexa Pharmaceticals on August 23, 2024 and sell it today you would lose (154.00) from holding Biodexa Pharmaceticals or give up 24.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biodexa Pharmaceticals vs. Entero Therapeutics,
Performance |
| Timeline |
| Biodexa Pharmaceticals |
| Entero Therapeutics, |
Biodexa Pharmaceticals and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biodexa Pharmaceticals and Entero Therapeutics,
The main advantage of trading using opposite Biodexa Pharmaceticals and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biodexa Pharmaceticals position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.The idea behind Biodexa Pharmaceticals and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Entero Therapeutics, vs. ZyVersa Therapeutics | Entero Therapeutics, vs. Sonnet Biotherapeutics Holdings | Entero Therapeutics, vs. Zura Bio Limited | Entero Therapeutics, vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |